Literature DB >> 12975417

Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis.

S Ye1, S Dhillon, R Seear, L Dunleavey, L B Day, W Bannister, I N M Day, I Simpson.   

Abstract

OBJECTIVE: To test the hypothesis that gene-gene interaction of the renin-angiotensin system is associated with an effect on the extent of coronary atherosclerosis. SETTING AND
RESULTS: A cohort of 1162 patients with coronary artery disease were genotyped for genetic polymorphisms in the renin-angiotensin system. Patients carrying the D allele of the angiotensin I converting enzyme (ACE) gene had greater coronary extent scores (defined as the number of coronary segments with 5% to 75% stenosis) than those not carrying this allele (p = 0.006 in non-parametric analysis and p = 0.019 in parametric analysis). This association remained significant after adjusting for age, body mass index, hypertension, and diabetes, which were also significantly associated with coronary extent scores. There was a significant interaction (p = 0.033) between genotypes of ACE and angiotensin II type 1 receptor (AGTR1). The association between the ACE gene D allele and increased coronary extent scores was significant (p = 0.008 in non-parametric and p = 0.027 in parametric analysis) in those carrying the +1166 C allele of the AGTR1 gene, but was absent in those not carrying the AGTR1 gene +1166 C allele.
CONCLUSION: These findings suggest that variation in the ACE and AGTR1 genes and their interaction may not only contribute to susceptibility of coronary artery disease as previously found but also modify the disease process, thus contributing to interindividual differences in severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975417      PMCID: PMC1767923          DOI: 10.1136/heart.89.10.1195

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

Review 1.  Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics.

Authors:  K M Dipple; E R McCabe
Journal:  Am J Hum Genet       Date:  2000-05-01       Impact factor: 11.025

Review 2.  Modifier genes in mice and humans.

Authors:  J H Nadeau
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

Review 3.  Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease.

Authors:  J G Wang; J A Staessen
Journal:  Eur J Pharmacol       Date:  2000-12-27       Impact factor: 4.432

4.  Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators.

Authors:  B Keavney; C McKenzie; S Parish; A Palmer; S Clark; L Youngman; M Delépine; M Lathrop; R Peto; R Collins
Journal:  Lancet       Date:  2000-02-05       Impact factor: 79.321

5.  Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis.

Authors:  A Gardemann; J Stricker; J Humme; Q D Nguyen; N Katz; M Philipp; H Tillmanns; F W Hehrlein; W Haberbosch
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

Review 6.  Angiotensin II and atherosclerosis.

Authors:  D Weiss; D Sorescu; W R Taylor
Journal:  Am J Cardiol       Date:  2001-04-19       Impact factor: 2.778

7.  Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.

Authors:  S Lutucuta; C M Ballantyne; H Elghannam; A M Gotto; A J Marian
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

Review 8.  The multiple actions of angiotensin II in atherosclerosis.

Authors:  K M Schmidt-Ott; S Kagiyama; M I Phillips
Journal:  Regul Pept       Date:  2000-09-25

9.  Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction.

Authors:  L Tiret; A Bonnardeaux; O Poirier; S Ricard; P Marques-Vidal; A Evans; D Arveiler; G Luc; F Kee; P Ducimetière
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

10.  Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland.

Authors:  P Pajukanta; M Cargill; L Viitanen; I Nuotio; A Kareinen; M Perola; J D Terwilliger; E Kempas; M Daly; H Lilja; J D Rioux; T Brettin; J S Viikari; T Rönnemaa; M Laakso; E S Lander; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-11-13       Impact factor: 11.043

View more
  10 in total

1.  Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits.

Authors:  M R Abdollahi; T R Gaunt; H E Syddall; C Cooper; D I W Phillips; S Ye; I N M Day
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

2.  Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.

Authors:  Cielito C Reyes-Gibby; Sanjay Shete; Trude Rakvåg; Samrat V Bhat; Frank Skorpen; Eduardo Bruera; Stein Kaasa; Pål Klepstad
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

3.  Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schonlein purpua nephritis.

Authors:  Jianhua Zhou; Xuefei Tian; Qinru Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

4.  Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis.

Authors:  Jian-Bo Zhou; Jin-Kui Yang; Jing-Kai Lu; Yan-Hua An
Journal:  Mol Biol Rep       Date:  2009-08-05       Impact factor: 2.316

5.  Interaction of G-protein beta3 subunit and nitric oxide synthase gene polymorphisms on carotid artery intima-media thickness in young adults: the Bogalusa Heart Study.

Authors:  Azad R Bhuiyan; Wei Chen; Sathanur R Srinivasan; Janet C Rice; Nancy B Mock; Rong Tang; M Gene Bond; Eric Boerwinkle; Gerald S Berenson
Journal:  Am J Hypertens       Date:  2008-06-12       Impact factor: 2.689

6.  Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels.

Authors:  Joanna Borzyszkowska; Anna Stanislawska-Sachadyn; Marcin Wirtwein; Wojciech Sobiczewski; Dariusz Ciecwierz; Radoslaw Targonski; Marcin Gruchala; Andrzej Rynkiewicz; Janusz Limon
Journal:  J Appl Genet       Date:  2012-02-04       Impact factor: 3.240

7.  Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer.

Authors:  Haixin Lei; Ian N M Day; Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2005-07-14       Impact factor: 16.971

8.  High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.

Authors:  Jeanne d'Arc AlBacha; Mira Khoury; Charbel Mouawad; Katia Haddad; Samar Hamoui; Albert Azar; Ziad Fajloun; Nehman Makdissy
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

9.  Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects.

Authors:  Shasha Luo; Chao Shi; Furu Wang; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-11-15       Impact factor: 3.390

10.  Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population.

Authors:  Anukriti Singh; Nidhi Srivastava; Sonal Amit; S N Prasad; M P Misra; Bushra Ateeq
Journal:  Transl Oncol       Date:  2018-02-03       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.